Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
about
Hypoxia-inducible factors as molecular targets for liver diseasesRoles of lipoprotein receptors in the entry of hepatitis C virusThree-dimensional Huh7 cell culture system for the study of Hepatitis C virus infectionRNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus EndocytosisA novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmissionClaudin association with CD81 defines hepatitis C virus entry.Production, purification and characterization of recombinant, full-length human claudin-1.The missing pieces of the HCV entry puzzle.Viruses and tetraspanins: lessons from single molecule approaches.The SR-BI partner PDZK1 facilitates hepatitis C virus entry.Regulated Entry of Hepatitis C Virus into Hepatocytes.Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses.HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.Species-specific regions of occludin required by hepatitis C virus for cell entry.Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR.Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infectionClaudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.Permissiveness of human hepatoma cell lines for HCV infection.A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infectionHepatitis C virus-host interactions, replication, and viral assemblyChimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent mannerVery-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.Hepatocyte polaritySHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core proteinHumanized murine model for HBV and HCV using human induced pluripotent stem cellsThe hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyCD81 and hepatitis C virus (HCV) infection.CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver.Role of lipid metabolism in hepatitis C virus assembly and entry.How hepatitis C virus invades hepatocytes: the mystery of viral entryAdvances and challenges in studying hepatitis C virus in its native environment.Adaptive immunity to the hepatitis C virus.Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.Hepatitis C virus entry: beyond receptors.The role of epithelial tight junctions involved in pathogen infections.
P2860
Q26752304-B68017C7-B653-429A-9AD2-78D3E35755FBQ26777338-B8A36A50-F5DB-4700-89B5-F789E0FF5336Q27489062-F504BD49-CAD7-4483-B8D1-33470030823FQ27490501-04CF81C5-54D7-4D75-8177-74231528ED13Q28488372-DA9A9B17-EB3E-4D8B-B61B-453A18B68CF1Q29465808-EF884E5B-5356-40F6-A93C-2BC1A46F0F1DQ31118101-D8E12A96-420A-44D0-91D3-0984AED1CCA8Q33360674-4D8E4A50-CB79-4D20-82AD-3C082EA395D4Q33677540-14EC4895-604B-41A1-B07E-46B3581E7E91Q33719403-CA547FAE-1E7B-4E72-AD7B-A54046BEE067Q33753913-8568DF85-BC00-4C5A-8B5C-87DD8D53A29BQ34026061-F3E00A52-2374-40B9-BC42-DA4EA335FA92Q34216377-1CE523E4-E308-4A8A-9C2E-EBEF9C5347C3Q34296017-E395AAF5-92B7-4DD7-AA81-3C2FCA0EAB83Q34649662-A76C99BA-33C7-4764-95F9-1539834E10ADQ34721015-AF126B4B-4AEB-4306-8147-C6E40AC23C91Q34799950-6001EDFB-E248-4718-8902-74EB5899AD92Q35839680-B3E5EA66-D9BC-4CC2-ACE5-FBD2D01D683BQ35866290-C315C8DD-F339-4754-9BD4-829882D73EEBQ35885451-D22963C4-B7F0-45A7-8511-E61C1D7D300CQ35999192-904CF7BA-8212-4D0B-A808-F60998EC7E85Q36427976-40F75A5C-B5B9-4B28-8CE4-AE39FF8C6A88Q36682313-AE9994D0-75BE-4AB2-9A2C-B09107D830E0Q36694938-2AA4D774-2D15-4855-8CA0-3BA1DC132B5CQ36760026-8FB418D6-0BA4-4703-9274-10FDFB21F738Q36972087-AEF726D3-7BE6-4AA3-85F4-947B7719702EQ37003890-FC39B21E-C641-455F-B4DB-8BA2B6031675Q37065853-3853FAB7-702A-4949-950D-874E6D6A1CE4Q37609487-631E5F40-F990-4186-99C0-B0EA26467114Q37609988-FAC47989-3EBF-473F-BD21-6B52DE6A7214Q37611819-2B28DC15-BC49-4A46-AFA0-B093E0A3BAD9Q37611842-66109DF6-675E-425C-ABBD-94ACA722A174Q37612385-217A05DF-5D26-4E3E-A331-9AFEA804A11CQ37621569-92BFD9F1-A191-4B13-BE86-DF326FFE86C8Q37682499-5005501B-885D-4E4C-8861-3EB3A3FB57DEQ37798816-1039474C-1BBF-4A0E-9F70-C18FF8D8BB3AQ37805839-88C8C2C6-5F01-408E-A221-DCDA736782E6Q37864742-920C4EB1-CD21-4A57-B2CE-F42DEC1E9880Q37990884-1F10EE9E-D760-4704-85FF-F5073E5B3D61Q38223244-91B66301-CC41-44F9-8EB9-17530DFB8163
P2860
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@ast
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@en
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@nl
type
label
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@ast
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@en
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@nl
prefLabel
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@ast
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@en
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
@en
P2093
Christopher Davis
Garrick Wilson
Gary Reynolds
Helen J Harris
Michelle J Farquhar
Sven C D van IJzendoorn
P2860
P304
P3181
P356
10.1128/JVI.00246-09
P577
2009-06-01T00:00:00Z